haploidentical sct for the treatment of secondary aml
Published 7 months ago • 38 plays • Length 2:13Download video MP4
Download video MP3
Similar videos
-
2:25
optimizing haplo-sct for the treatment of aml
-
3:10
the efficacy of haploidentical transplantation in aml and all
-
2:57
the importance of analyzing cytogenetic risk in patients with aml undergoing haploidentical sct
-
2:00
haploidentical transplantation for aml with mrd at transplantation
-
1:42
novel treatment combinations in aml: what’s to come?
-
2:21
practical considerations for dli after haploidentical sct
-
14:43
current research into post-allosct maintenance therapy in aml
-
36:22
myeloid series part 1
-
4:05
apollo: ato-atra versus standard atra chemotherapy for patients with newly diagnosed high-risk apl
-
1:19
astx727 a molecularly-targeted agent as personalized maintenance therapy in patients with aml
-
1:26
incidence and risk factors associated with vod/sos in younger vs older adults after sct
-
2:45
the value of axi-cel as a second-line treatment in r/r lbcl
-
2:33
novel immunotherapies in aml and insights into the future of the treatment landscape
-
1:24
conventional approaches for all targeted therapies in allo-hsct
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
8:57
outcomes of sct in t-all and t-lbl
-
3:46
the impact of cytogenetic risk on outcomes of haploidentical transplantation in r/r aml
-
4:36
aml haplo-hsct outcomes
-
2:34
the evolution of the aml treatment paradigm
-
3:58
targeted treatments for aml: the revolution
-
3:37
the future of aml treatment